tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ADAG Stock Latest News

Adagene’s Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating
RatingsAdagene’s Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating
7d ago
ADAG
Adagene Inc. Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Adagene Inc. Reports 2024 Financial Results and Progress
17d ago
ADAG
Adagene Reports 2024 Financial Results and Advances Clinical Programs
PremiumCompany Announcements
Adagene Reports 2024 Financial Results and Advances Clinical Programs
17d ago
6K
ADAG
Adagene reports FY24 adjusted EPS (51c), consensus (58c)
PremiumThe Fly
Adagene reports FY24 adjusted EPS (51c), consensus (58c)
17d ago
ADAG
Adagene sees cash runway into late 2026
PremiumThe Fly
Adagene sees cash runway into late 2026
17d ago
ADAG
Adagene begins Phase 2 trial for neoadjuvant muzastotug in colorectal cancer
PremiumThe FlyAdagene begins Phase 2 trial for neoadjuvant muzastotug in colorectal cancer
1M ago
ADAG
Adagene downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Adagene downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
ADAG
Adagene Reports Promising Results in Colorectal Cancer Study
Premium
Company Announcements
Adagene Reports Promising Results in Colorectal Cancer Study
2M ago
6K
ADAG
Adagene announces updated data from Phase 1b/2 study of muzastotug, keytruda
PremiumThe Fly
Adagene announces updated data from Phase 1b/2 study of muzastotug, keytruda
2M ago
MRK
ADAG
Adagene price target raised to $8 from $5 at H.C. Wainwright
PremiumThe Fly
Adagene price target raised to $8 from $5 at H.C. Wainwright
2M ago
ADAG
Adagene to host virtual KOL event to discuss SAFEbodyADG126
PremiumThe Fly
Adagene to host virtual KOL event to discuss SAFEbodyADG126
3M ago
ADAG
Adagene downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Adagene downgraded to Hold from Buy at Jefferies
5M ago
ADAG
Adagene Unveils Promising Data for Cancer Therapy
PremiumCompany AnnouncementsAdagene Unveils Promising Data for Cancer Therapy
5M ago
6K
ADAG
Adagene presents data on ADG126 at SITC Annual Meeting
Premium
The Fly
Adagene presents data on ADG126 at SITC Annual Meeting
5M ago
ADAG
Adagene’s ADG126 Shows Promise in MSS CRC Therapy
Premium
Company Announcements
Adagene’s ADG126 Shows Promise in MSS CRC Therapy
7M ago
6K
ADAG
Adagene’s Promising Mid-Year Financials and ADG126 Update
PremiumCompany Announcements
Adagene’s Promising Mid-Year Financials and ADG126 Update
9M ago
6K
ADAG
Adagene Inc. Strikes Deal to Sell Depositary Shares
PremiumCompany Announcements
Adagene Inc. Strikes Deal to Sell Depositary Shares
1y ago
6K
ADAG
Adagene’s Breakthroughs Promise Future Growth
PremiumCompany Announcements
Adagene’s Breakthroughs Promise Future Growth
1y ago
6K
ADAG
Adagene announces progress in program for ADG126 and KEYTRUDA
PremiumThe Fly
Adagene announces progress in program for ADG126 and KEYTRUDA
1y ago
ADAG
Morgan Stanley ‘encouraged’ by 2 cPRs reported by Adagene
PremiumThe FlyMorgan Stanley ‘encouraged’ by 2 cPRs reported by Adagene
1y ago
ADAG
Adagene falls after presenting interim results from study of ADG126
Premium
The Fly
Adagene falls after presenting interim results from study of ADG126
1y ago
MRK
ADAG
Adagene price target lowered to $4.60 from $5 at Morgan Stanley
Premium
The Fly
Adagene price target lowered to $4.60 from $5 at Morgan Stanley
1y ago
ADAG

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >